Hired by two ex-Citi Managing Directors of Investment Banking to prepare the high-growth company for private and public capital raising events to fund value-accretive projects, e.g., US expansion, platform development. The project was recently abandoned. - Led the Financial Planning and Analysis providing monthly variance analysis and strategic financial insights to executive leadership, board members and investors. - Oversaw full-scope and cross-functional Due Diligence process from Tier-1 global Private Equity and Sovereign Wealth Funds and designed management presentations related to capital raising activities, addressing the equity story, market opportunity, investors considerations and valuation perspectives from the triangulation of Discounted Cash Flows, Trading Multiples, Precedents and IPO methods. - Developed Pro Forma strategic models, e.g., i) for the contemplated takeover of Babylon Health (NYSE: BBLN) operating subsidiaries, with $ 1bn revenue in FY22A, in a take-private buyout fashion and ii) for joint distribution partnerships with leading pharmaceuticals companies in Japan and the US.

- Executed financial due diligence on multi-billion-dollar transactions, delivering in-depth analysis on key business drivers, earnings quality, cash flow, working capital and net assets for leading Private Equity firms and corporate acquirers. - Engineered financial models with the triangulation of Discounted Cash Flows, Trading Multiples and Precedents methods, ensuring accurate and insightful valuations. - Managed transaction documentation, including proposals, engagement letters, and memoranda for major M&A deals, supporting strategic decision-making in high-stakes transactions.